Linkpad for week ending November 8th, 2013

  • I'm excited to announce the launch of our new website that highlights two very important Eli Lilly global health programs, which we have spotlighted on our blog previously: the Lilly MDR-TB Partnership and the Lilly NCD Partnership. This new website will serve as a place to learn about the enormous impact of multidrug-resistant tuberculosis (MDR-TB) and non-communicable diseases (NCDs) worldwide, as well as to view our progress with our partners as we work to find solutions to these urgent global health challenges.

Please visit www.lillyglobalhealth.com

  • Rob Oliphant, President and CEO of the Asthma Society of Canada tackles the Canada-EU Comprehensive Economic and Trade Agreement (CETA) in his piece in Huffington Post Canada. Mr. Oliphant stresses the importance of stronger patent protections to patients living with chronic conditions, writing:

"Strengthening Canada's IP standards is not only a key pillar of a trade agreement that will bring greater prosperity to Canada; it will also create an environment that encourages medical innovation and creates new opportunities for patients seeking a cure or relief from pain."

Read the full article: Taking Prescription Medication? You Could Benefit from CETA

  • Canada is lagging in health technology adoption. Russell Williams, President of Rx&D, Canada's Research Based Pharmaceutical Companies, looked into this issue, why we should be concerned and what is being done about it:

"Early adoption of technologies is a key element to improving our productivity, transforming our economies, sustaining our health care systems and sending a signal that we want to compete and run with the best.

Check out the full piece over at HuffPost Canada: http://www.huffingtonpost.ca/russell-williams/technology-and-healthcare-canada_b_4227253.html

  • Finally, this week the federal government announced funding for new research projects aimed at preventing, diagnosing and treating concussions. Six research projects in Ontario received total funding of $2.7M from the Canadian Institutes of Health Research (CIHR), Defence Research and Development Canada, Ontario Neurotrauma Foundation and Ontario Brain Institute.

Read more about the projects selected: CIHR Mild Traumatic Brain Injury Research Funding